Immunization associated with primary tumor growth leads to rejection of commonly used syngeneic tumors upon tumor rechallenge

The recent success of multiple immunomodulating drugs in oncology highlights the potential of relieving immunosuppression by directly engaging the immune system in the tumor bed to target cancer cells. Durable responses to immune checkpoint inhibitors experienced by some patients may be indicative o...

Descripción completa

Detalles Bibliográficos
Autores principales: Alicke, Bruno, Totpal, Klara, Schartner, Jill M, Berkley, Amy M, Lehar, Sophie M, Capietto, Aude-Hélène, Cubas, Rafael A, Gould, Stephen E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7368499/
https://www.ncbi.nlm.nih.gov/pubmed/32675310
http://dx.doi.org/10.1136/jitc-2020-000532

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7368499/
https://www.ncbi.nlm.nih.gov/pubmed/32675310
http://dx.doi.org/10.1136/jitc-2020-000532

Ejemplares similares